tiprankstipranks
Advertisement
Advertisement

Interpace Biosciences sees FY26 revenue $40M

This represents growth of approximately 16% in thyroid testing revenue over 2025.

Claim 30% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1